To extend these findings to our ALM patient cohort, we decided to explore the infiltration of immunosuppressive TAMs in ALM biopsies using IHC against CD163, a well-established marker of immunosuppressive macrophages. Here, CD163 is linked to acral lentiginous melanoma.